Children with Cancer UK
Every year, almost 4,000 families are given the devastating news that their child has cancer, and sadly, 500 young lives lose their battle.
No child should die from cancer. That’s why Children with Cancer UK invests millions of pounds every year into cutting edge research: to help us understand why children get cancer in the first place and to better treat it, so that one day we can save the life of every young patient. We also fund innovative welfare projects to provide better care and practical support for young cancer patients and their families. This can involve financial support, accommodation for adults when their child has to stay in hospital overnight, or even giving them a special day to remember during some of the most difficult years of their lives.
We can’t do all of this alone. We are delighted that Eden Private Staff have chosen to support Children with Cancer UK to help save more children in their fight against cancer.
Eva was 18 months old when she was diagnosed with Wilms’ Tumour, a rare kidney cancer.
“On the 10th November 2013 we took our precious daughter Eva to the emergency doctor, as she had shown worrying signs that she wasn’t well. The doctors seemed extremely concerned, and it was at this point Eva’s life changed forever…
Eva has had more than 40 rounds of chemo, two major surgeries (including the loss of a kidney), three minor surgeries, and two rounds of radiotherapy. She has had countless blood transfusions and dressing changes as well as hundreds of blood samples taken. Eva has had numerous ambulance rides and has spent months in hospital. She has endured scans, stem cell harvesting, high-dose chemo and a stem cell transplant.
And after it all, Eva has hardly complained. Nurses even nick-named her ‘Eva The Brave’ for her fighting spirit and big smile. Today, Eva is three and is still undergoing treatment.”
Because of you, we can help more brave children like little Eva.
With your help we can invest in:
Further research into our Paediatric Brain Tumour Initiative
Brain tumours are one of the most common cancers affecting children and young people. They cause more deaths in this age group than any other cancer, yet research in the past has been heavily underfunded. Children with Cancer UK are addressing this and are making research in this area a strategic priority over the next 5 years as part of our Paediatric Brain Tumour Initiative.
Around 400 children are diagnosed with a brain tumour every year in the UK and only few are curable – using aggressive treatments including surgery, chemotherapy and/or radiotherapy to fight them. Other brain tumours, however, remain incurable, with no effective treatment. Devastatingly, some children may survive only two or three months from diagnosis. For those who do survive, this may come at a high cost. The treatments currently used are extremely harsh on little bodies and can harm developing brains, causing physical and mental disabilities such as severely lowered IQ levels, learning disabilities, epilepsy, loss of hearing and loss of sight.
With your support we can fund Dr Steven Pollard’s research to further understand the genetics of paediatric glioblastoma – the devastating brain tumour that sees less than 20% of young patients survive.
Research into childhood leukaemias (blood cancers)
Leukaemia is a cancer of the white blood cells, which is part of our body’s immune system. These cancerous cells fill up the bone marrow and stop it making healthy blood cells, putting the child at increased risk of infection. Symptoms such as bruising and anaemia are caused by the bone marrow’s inability to make enough healthy red blood cells and platelets.
With your help we can continue to support Professor Persis Amrolia’s research into a new type of treatment: Immunotherapy, which fights leukaemia when chemotherapy and radiotherapy aren’t responsive.
Research into childhood neuroblastomas (spinal and nervous system cancers)
Neuroblastoma is the second most common solid tumour in childhood, affecting just under 100 children a year in the UK.
Neuroblastoma can occur anywhere in the body, but it most often occurs in one of the adrenal glands, in the abdomen. In some children, the neuroblastoma occurs in nerve tissue alongside the spinal cord in the neck, chest, abdomen or pelvis.
Neuroblastoma has one of the lowest survival rates of all childhood cancers, with only 67 per cent of patients surviving to five years. This is an injustice we must combat.
With your support we can invest further into Dr Yann Jamin’s research to develop personalised treatments for children with neuroblastoma using MRI scans.